Foresight Diagnostics lab (courtesy Foresight)
Foresight Diagnostics' approach for the earlier detection of cancer recurrence pulls in nearly $59M
In a crowded field of cancer diagnostics companies looking to detect relapses earlier, Foresight Diagnostics thinks it has a more sensitive approach. On Thursday, it …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
